Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Hirotsu

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 22, 2014
Transcription factor NF-E2-related factor 1 impairs glucose metabolism in miceYosuke Hirotsu, Chika Higashi, Toshiaki Fukutomi, et al.
Oncotarget|September 24, 2017
Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral bloodTaichiro Goto, Yosuke Hirotsu, Kenji Amemiya, et al.
Respiratory Medicine Case Reports|March 10, 2017
Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancerYoshihiro Miyashita, Yosuke Hirotsu, Toshiharu Tsutsui, et al.
Cancer Cytopathology|April 19, 2021
Actionable driver DNA variants and fusion genes can be detected in archived cytological specimens with the Oncomine Dx Target Test Multi-CDx system in lung cancerKenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 25, 2024
The efficacy of bile liquid biopsy in the diagnosis and treatment of biliary tract cancerYoshifumi Miura, Hiroshi Ohyama, Rintaro Mikata, et al.
Scientific Reports|May 30, 2024
Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancerYuki Nagakubo, Yosuke Hirotsu, Mona Yoshino, et al.
Gynecologic Oncology|November 1, 2025
Preoperative molecular classification of endometrial cancer: Validation through biopsy and matched hysterectomy specimensTakahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, et al.
JTO Clinical and Research Reports|June 6, 2024
Brief Report: Tepotinib as a Treatment Option in <i>MET</i> Exon 14 Skipping-Positive Lung Cancers-Investigating Discordance Between ArcherMET and the Oncomine Dx Target TestYoshihiro Miyashita, Yosuke Hirotsu, Yuki Nagakubo, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 17, 2021
The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errorsMasao Omata, Yosuke Hirotsu, Hiroki Sugiura, et al.
Cancers|December 6, 2018
Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3Takahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 22, 2014
Transcription factor NF-E2-related factor 1 impairs glucose metabolism in miceYosuke Hirotsu, Chika Higashi, Toshiaki Fukutomi, et al.
Oncotarget|September 24, 2017
Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral bloodTaichiro Goto, Yosuke Hirotsu, Kenji Amemiya, et al.
Respiratory Medicine Case Reports|March 10, 2017
Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancerYoshihiro Miyashita, Yosuke Hirotsu, Toshiharu Tsutsui, et al.
Cancer Cytopathology|April 19, 2021
Actionable driver DNA variants and fusion genes can be detected in archived cytological specimens with the Oncomine Dx Target Test Multi-CDx system in lung cancerKenji Amemiya, Yosuke Hirotsu, Yuki Nagakubo, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 25, 2024
The efficacy of bile liquid biopsy in the diagnosis and treatment of biliary tract cancerYoshifumi Miura, Hiroshi Ohyama, Rintaro Mikata, et al.
Scientific Reports|May 30, 2024
Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancerYuki Nagakubo, Yosuke Hirotsu, Mona Yoshino, et al.
Gynecologic Oncology|November 1, 2025
Preoperative molecular classification of endometrial cancer: Validation through biopsy and matched hysterectomy specimensTakahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, et al.
JTO Clinical and Research Reports|June 6, 2024
Brief Report: Tepotinib as a Treatment Option in <i>MET</i> Exon 14 Skipping-Positive Lung Cancers-Investigating Discordance Between ArcherMET and the Oncomine Dx Target TestYoshihiro Miyashita, Yosuke Hirotsu, Yuki Nagakubo, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 17, 2021
The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errorsMasao Omata, Yosuke Hirotsu, Hiroki Sugiura, et al.
Cancers|December 6, 2018
Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3Takahiro Nakagomi, Taichiro Goto, Yosuke Hirotsu, et al.
Pageof 13